These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25544586)

  • 1. Repolarization Lability Measured by Spatial TT' Angle.
    Tereshchenko LG
    Comput Cardiol (2010); 2014 Sep; 41():181-184. PubMed ID: 25544586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beat-to-beat spatiotemporal variability in the T vector is associated with sudden cardiac death in participants without left ventricular hypertrophy: the Atherosclerosis Risk in Communities (ARIC) Study.
    Waks JW; Soliman EZ; Henrikson CA; Sotoodehnia N; Han L; Agarwal SK; Arking DE; Siscovick DS; Solomon SD; Post WS; Josephson ME; Coresh J; Tereshchenko LG
    J Am Heart Assoc; 2015 Jan; 4(1):e001357. PubMed ID: 25600143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients.
    Tereshchenko LG; Han L; Cheng A; Marine JE; Spragg DD; Sinha S; Dalal D; Calkins H; Tomaselli GF; Berger RD
    Heart Rhythm; 2010 Nov; 7(11):1606-13. PubMed ID: 20816873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repolarization lability measured on 10-second ECG by spatial TT' angle: reproducibility and agreement with QT variability.
    Feeny A; Han L; Tereshchenko LG
    J Electrocardiol; 2014; 47(5):708-15. PubMed ID: 25012076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sum absolute QRST integral, and temporal variability in depolarization and repolarization, measured by dynamic vectorcardiography approach, in healthy men and women.
    Sur S; Han L; Tereshchenko LG
    PLoS One; 2013; 8(2):e57175. PubMed ID: 23451181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Specific Time-Varying Association between Spatial and Temporal Variability in Repolarization and High Sensitivity Troponin I.
    Tereshchenko LG; Feeny A
    Comput Cardiol (2010); 2016 Sep; 43():333-336. PubMed ID: 28936465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beat-to-beat determinants of the beat-to-beat temporal and spatial variability of repolarization.
    Feeny A; Tereshchenko LG
    J Electrocardiol; 2016; 49(3):417-22. PubMed ID: 26874566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure.
    Francia P; Adduci C; Semprini L; Stanzione R; Serdoz A; Caprinozzi M; Santini D; Cotugno M; Palano F; Musumeci MB; Rubattu S; Volpe M
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):656-61. PubMed ID: 25773045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of biventricular pacing on ventricular repolarization and functional indices in patients with heart failure: lack of association with arrhythmic events.
    Dilaveris P; Giannopoulos G; Synetos A; Aggeli C; Raftopoulos L; Arsenos P; Gatzoulis K; Stefanadis C
    Europace; 2009 Jun; 11(6):741-50. PubMed ID: 19376820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of ventricular tachyarrhythmias by intracardiac repolarization variability analysis.
    Tereshchenko LG; Fetics BJ; Domitrovich PP; Lindsay BD; Berger RD
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):276-84. PubMed ID: 19808478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic total occlusion of an infarct-related artery: a new predictor of ventricular arrhythmias in primary prevention implantable cardioverter defibrillator patients.
    Di Marco A; Anguera I; Teruel L; Dallaglio P; González-Costello J; León V; Nuñez E; Manito N; Gómez-Hospital JA; Sabaté X; Cequier Á
    Europace; 2017 Feb; 19(2):267-274. PubMed ID: 28175266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
    Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia.
    Evonich RF; Maheshwari A; Gardiner JC; Khasnis A; Kantipudi S; Ip JH; Grimes D; Hayter G; Thakur RK
    J Interv Card Electrophysiol; 2004 Aug; 11(1):59-65. PubMed ID: 15273456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.